| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |